Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Rauser, G.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Availability
Metadata Only
(2)
+
-
Creation Date
2018
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(2)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(2)
+
-
Author
Assenmacher, M.
(2)
+
-
Balen, P. van
(2)
+
-
Egmond, E.H.M. van
(2)
+
-
Falkenburg, J.H.F.
(2)
+
-
Halkes, C.J.M.
(2)
+
-
Hoogstraten, C.
(2)
+
-
Jedema, I.
(2)
+
-
Kersting, S.
(2)
+
-
Liempt, E.A.G. van
(2)
+
-
Meij, P.
(2)
+
-
Rauser, G.
(2)
+
-
Veld, S.A.J.
(2)
+
-
Zwaginga, J.J.
(2)
+
-
Show more
Language
en
(2)
+
-
Search results
(1 - 2 of 2)
show grid
show list
save search
Jedema, I.; Balen, P. van; Halkes, C.J.M.; Egmond, E.H.M. van; Liempt, E.A.G. van; Veld, S.A.J.; ... ; Falkenburg, J.H.F.
2018
Phase I/II clinical trial demonstrates feasibility, safety and effectivity of CMV-pp65-specific donor T-cells for the treatment of refractory CMV reactivation after allogeneic stem cell transplantation
Article / Letter to editor
metadata only
Jedema, I.; Balen, P. van; Halkes, C.J.M.; Egmond, E.H.M. van; Liempt, E.A.G. van; Veld, S.A.J.; ... ; Falkenburg, J.H.F.
2018
Phase I/II clinical trial demonstrates feasibility, safety and effectivity of CMV-pp65-specific donor T-cells for the treatment of refractory CMV reactivation after allogeneic stem cell transplantation
Other
metadata only
